This report describes a murine amniotic fluid (MAF) immunosuppressive factor that has properties similar to transforming growth factor beta (TGF-beta). The MAF factor exhibits TGF-beta-like activity in stimulating soft agar colony formation by AKR-2B cells and inhibiting thymidine uptake by Mv1Lu cells. We demonstrate that both the immunosuppressive and TGF-beta-like activities of the MAF factor are completely neutralized by anti-TGF-beta 2-specific antibodies and not by anti-TGF-beta 1-specific antisera. The immunosuppressive factor in MAF is novel in that it appears to be identical or very closely related to TGF-beta 2 and is active in its native state. This active and anti-TGF-beta 2-neutralizable factor chromatographs at approximately 70 kD on Sephadex at neutral pH and appears to be able to complex with alpha-fetoprotein in native amniotic fluid. Chromatography of native MAF under acidic conditions demonstrates a lower molecular mass protein that chromatographs on BioGel in the same position as the mature 25-kD TGF-beta. This protein has the biological properties of TGF-beta and is immunosuppressive. Both of these activities are neutralizable with anti-TGF-beta 2 but not with anti-TGF-beta 1 or other antisera. By Northern analysis, we find high levels of TGF-beta 2 mRNA (with little or no TGF-beta 1) in the pregnant uterus that peak around day 15 of gestation and then fall rapidly by day 19 as birth approaches. The TGF-beta 2-like factor could possibly play a role in maternal immunity, in the retention of the fetal allograft, as well as in regulating fetal and neonatal immunological competence.
Skip Nav Destination
Article navigation
1 November 1990
Article|
November 01 1990
A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.
D J Altman,
D J Altman
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Search for other works by this author on:
S L Schneider,
S L Schneider
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Search for other works by this author on:
D A Thompson,
D A Thompson
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Search for other works by this author on:
H L Cheng,
H L Cheng
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Search for other works by this author on:
T B Tomasi
T B Tomasi
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Search for other works by this author on:
D J Altman
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
S L Schneider
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
D A Thompson
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
H L Cheng
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
T B Tomasi
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1990) 172 (5): 1391–1401.
Citation
D J Altman, S L Schneider, D A Thompson, H L Cheng, T B Tomasi; A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.. J Exp Med 1 November 1990; 172 (5): 1391–1401. doi: https://doi.org/10.1084/jem.172.5.1391
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement